ASCENDIS PHARMA A/S: Financial statements 2021
CVR: 29918791
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
ASCENDIS PHARMA A/S (CVR 29918791) has filed annual accounts for 2021. In 2021, the company reported revenue of EUR 7,778,000 and a net result of EUR -383,577,000 compared with EUR -418,955,000 the year before. That is an increase of 11.9% compared with the year before. The profit margin was -4,931.6%. Equity in the 2021 report amounted to EUR 883,635,000. The solvency ratio was 81.4%.
- Revenue
- EUR 7,778,000
- Gross Profit
- EUR 4,255,000
- Profit/Loss
- EUR -383,577,000
- Equity
- EUR 883,635,000
- Total Assets
- EUR 1,084,921,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 7.8 mio. EUR | 4.3 mio. EUR | -383.6 mio. EUR | 883.6 mio. EUR | - |
| 2020 | 7 mio. EUR | - | -419 mio. EUR | 838.7 mio. EUR | - |
| 2019 | 13.4 mio. EUR | - | -218 mio. EUR | 597.1 mio. EUR | - |
| 2018 | 10.6 mio. EUR | - | -130.1 mio. EUR | 280.1 mio. EUR | - |
| 2017 | 1.5 mio. EUR | - | -123.9 mio. EUR | 187.2 mio. EUR | - |
Official annual report
Find more companies like ASCENDIS PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of November 18, 2021, Rafaèle Tordjman has joined the board of directors of ASCENDIS PHARMA A/S.
As of October 8, 2021, Anni Lotte Kirstine Pedersen is registered as director of ASCENDIS PHARMA A/S.
As of July 12, 2021, Birgitte Volck has left the board of directors of ASCENDIS PHARMA A/S.
ASCENDIS PHARMA A/S has published its annual report for 2020. Revenue came to DKK 6,953,000, and the net result was DKK -418,955,000.
As of May 28, 2021, Albert Cha has joined the board of directors of ASCENDIS PHARMA A/S.
As of May 28, 2021, Michael Wolff Jensen has left the board of directors of ASCENDIS PHARMA A/S.
As of May 28, 2021, Michael Wolff Jensen is registered as director of ASCENDIS PHARMA A/S.
As of May 27, 2021, Albert Cha has left the board of directors of ASCENDIS PHARMA A/S.
About ASCENDIS PHARMA A/S
ASCENDIS PHARMA A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ASCENDIS PHARMA ApS and CADENZA PARTNERS ApS. The management consists of Jan Møller Mikkelsen, Anni Lotte Kirstine Pedersen and Michael Wolff Jensen. The board consists of Albert Cha (chair), Jan Møller Mikkelsen, Jean-Jacques Bienaime and Lars Holtug. The company is owned by Cede & Co. The company has 688 employees (2026). In 2025, the company reported revenue of EUR 720,132,000 and a net result of EUR -228,034,000 compared with EUR -378,084,000 the year before. Equity in the 2025 report amounted to EUR -162,821,000.